¼¼°èÀÇ º¸Åø¸®´®Åå½Å(º¸Å彺) ½ÃÀå
Botulinum Toxin
»óǰÄÚµå : 1768219
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 353 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,195,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,585,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

º¸Åø¸®´®Åå½Å(º¸Å彺) ¼¼°è ½ÃÀåÀº 2030³â±îÁö 110¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 67¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â º¸Åø¸®´®Åå½Å(º¸Å彺) ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö CAGR 8.8%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 110¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ À¯Çü A´Â CAGR 8.8%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á±îÁö 110¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯Çü B ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 7.4%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 39¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 16.0%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ º¸Åø¸®´®Åå½Å(º¸Å彺) ½ÃÀåÀº 2024³â¿¡ 39¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 12¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 16.0%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 8.6%¿Í 7.1%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 9.6%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ º¸Åø¸®´®Åå½Å(º¸Å彺) ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

º¸Åø¸®´®Åå½ÅÀ̶õ ¹«¾ùÀ̸ç, Çö´ë ÀÇÇп¡¼­ ¾î¶»°Ô Ȱ¿ëµÇ°í Àִ°¡?

º¸Å彺·Î ÀϹÝÀûÀ¸·Î ¾Ë·ÁÁø º¸Åø¸®´®Åå½ÅÀº º¸Åø¸®´® ±Õ¿¡ ÀÇÇØ »ý»êµÇ´Â ½Å°æµ¶¼º ´Ü¹éÁúÀÔ´Ï´Ù. °¡Àå µ¶¼ºÀÌ °­ÇÑ »ý¹°ÇÐÀû ¹°Áú Áß ÇϳªÀÌÁö¸¸, Á¤Á¦µÇ°í ¹Ì·®À¸·Î Á¶ÀýµÇ¾î »ç¿ëµÇ¸é ´Ù¾çÇÑ Áß¿äÇÑ ÀÇ·á ¹× ¹Ì¿ë¿¡ ÀÀ¿ëµÉ ¼ö ÀÖ½À´Ï´Ù. ÀÇÇÐÀûÀ¸·Î º¸Åø¸®´®Åå½ÅÀº ´«²¨Ç® °æ·Ã(´« ±ôºýÀÓÀÌ Á¶ÀýµÇÁö ¾ÊÀ½), »ç½Ã(´«ÀÌ ±³Â÷µÊ), °æºÎ ±Ù±äÀåÀÌ»óÁõ(°íÅ뽺·¯¿î ¸ñ ±ÙÀ° °æ·Ã), ¸¸¼º ÆíµÎÅë µî ´Ù¾çÇÑ ±ÙÀ° °æ·Ã Àå¾ÖÀÇ Ä¡·á¿¡ »ç¿ëµË´Ï´Ù. ±ÙÀ° ¼öÃàÀ» À¯¹ßÇÏ´Â ½Å°æÀü´Þ¹°ÁúÀÎ ¾Æ¼¼Æ¿Äݸ°ÀÇ ¹æÃâÀ» ¾ïÁ¦ÇÏ¿© ±ÙÀ°À» À̿ϽÃŰ´Â ÀÛ¿ëÀ» ÇÕ´Ï´Ù. ¹Ì¿ë Ãø¸é¿¡¼­´Â ¾ó±¼ ±ÙÀ°À» ÀϽÃÀûÀ¸·Î ¸¶ºñ½ÃÄÑ ÁÖ¸§À» ¾ø¾Ö´Â ¸ñÀûÀ¸·Î »ç¿ëµÇ´Â °ÍÀÌ °¡Àå À¯¸íÇϸç, ³ëÈ­ ¹æÁö Ä¡·áÁ¦·Îµµ ÀαⰡ ÀÖ½À´Ï´Ù.

º¸Åø¸®´®Åå½Å Ä¡·áÀÇ È¿°ú¿Í ¾ÈÀü¼ºÀ» ³ôÀÌ´Â ±â¼ú ¹ßÀü

º¸Åø¸®´®Åå½Å Ä¡·á ºÐ¾ß¿¡¼­´Â ±× È¿°ú¿Í ¾ÈÀü¼ºÀ» ³ôÀ̱â À§ÇÑ ±â¼úÀû ÁøÀüÀÌ µÎµå·¯Áö°Ô ³ªÅ¸³ª°í ÀÖ½À´Ï´Ù. Á¤Á¦ °øÁ¤°ú Á¦Çü ±â¼úÀÇ Çâ»óÀ¸·Î ƯÁ¤ Ä¡·á ¹× ¹Ì¿ë ¿ëµµ¿¡ ¸Â´Â ¿©·¯ Á¾·ùÀÇ º¸Åø¸®´®Åå½Å Á¦Ç°ÀÌ °³¹ßµÇ¾ú½À´Ï´Ù. ¶ÇÇÑ, ÀÇ·á ¿µ»ó ¹× ÁÖ»ç ±â¼úÀÇ Çõ½ÅÀ¸·Î µ¶¼Ò Åõ¿©ÀÇ Á¤È®µµ°¡ Çâ»óµÇ°í, È¿°ú°¡ Çâ»óµÇ°í, ºÎÀÛ¿ëÀÌ °¨¼ÒÇß½À´Ï´Ù. ¶ÇÇÑ, º¸Åø¸®´®Åå½ÅÀÇ ºÐÀÚ ±¸Á¶¿Í ¾àµ¿Çп¡ ´ëÇÑ ÇöÀç ÁøÇà ÁßÀÎ ¿¬±¸´Â È¿°ú°¡ ´õ ¿À·¡ Áö¼ÓµÇ°í, ÀÛ¿ëÀÌ ´õ »¡¸® ³ªÅ¸³ª¸ç, ¸é¿ª¿ø¼ºÀÌ °¨¼ÒµÈ ½ÅÁ¦Ç°À» Á¦°øÇÒ ¼ö ÀÖ¾î ±× »ç¿ëÀÌ È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º¸Åø¸®´®Åå½Å Àû¿ëÀÇ »õ·Î¿î Æ®·»µå

Àü ¼¼°è Àα¸ÀÇ °í·ÉÈ­¿¡ µû¶ó º¸Åø¸®´®Åå½ÅÀ» ÀÌ¿ëÇÑ ¹Ì¿ë Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Å©°Ô Áõ°¡Çϰí ÀÖÀ¸¸ç, ±× Àαâ¿Í ¼ö¿ëµµ°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¹Ì¿ë»Ó¸¸ ¾Æ´Ï¶ó °ú¹Î¼º ¹æ±¤ Ä¡·á µî ¹ÌÃæÁ· ÀÇ·á ¼ö¿ä°¡ ³ôÀº Ä¡·á ºÐ¾ß¿¡¼­µµ º¸Åø¸®´®Åå½ÅÀ» »ç¿ëÇÏ´Â Ãß¼¼°¡ ³ªÅ¸³ª¸é¼­ ÀÌ ¼è¾àÇØÁø »óÅ¿¡ ½Ã´Þ¸®´Â ȯÀڵ鿡°Ô »õ·Î¿î Ȱ·ÂÀ» ºÒ¾î³Ö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±ÙÀ°À» À̿ϽÃ۰í ÀÌ·¯ÇÑ Á¤½Å Áúȯ°ú °ü·ÃµÈ Áõ»óÀ» ¿ÏÈ­½Ãų ¼ö ÀÖ´Â µ¶¼ÒÀÇ ´É·ÂÀ» ¹ÙÅÁÀ¸·Î ¿ì¿ïÁõ°ú ºÒ¾ÈÁõ Ä¡·á¿Í °°Àº »õ·Î¿î Ä¡·á¹ý Àû¿ë °¡´É¼ºÀ» ¸ð»öÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿ëµµÀÇ ÁøÈ­´Â ÀÌ ºÐ¾ßÀÇ ¿ªµ¿ÀûÀΠƯ¼ºÀ» ¹Ý¿µÇϸç, º¸Åø¸®´®Åå½Å°¡ ±âÁ¸ÀÇ ¿ëµµ¸¦ ³Ñ¾î¼­´Â Å« ¿µÇâ·ÂÀ» ¹ßÈÖÇÒ ¼ö ÀÖ´Â ÀáÀç·ÂÀ» º¸¿©ÁÝ´Ï´Ù.

º¸Åø¸®´®Åå½Å ½ÃÀåÀÇ ¼ºÀå ¿øµ¿·ÂÀº?

º¸Åø¸®´®Åå½Å ½ÃÀåÀÇ ¼ºÀåÀº ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖÀ¸¸ç, ³²³à ¸ðµÎ ÃÖ¼Òħ½ÀÀû ¹Ì¿ë Ä¡·áÀÇ ¼ö¿ë°ú ¼ö¿ä Áõ°¡·Î ÀÎÇØ º¸Åø¸®´®Åå½Å ½ÃÀåÀÇ ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. Àü ¼¼°è °í·ÉÈ­À²ÀÇ Áõ°¡µµ ÁÖ¿ä ÃËÁø¿äÀÎÀ¸·Î, ÀþÀº ¿Ü¸ð¸¦ À¯ÁöÇϱâ À§ÇØ Ä¡·á¸¦ ã´Â »ç¶÷µéÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Ä¡·á¸¦ º¸´Ù ¾ÈÀüÇϰí È¿°úÀûÀ¸·Î ¸¸µå´Â ±â¼úÀÇ ¹ßÀüµµ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Ä¡·á ÀûÀÀÁõ È®´ë·Î ÀÎÇØ º¸´Ù ±¤¹üÀ§ÇÑ Áúȯ¿¡ ´ëÇÑ »õ·Î¿î ¼ºÀå ºÐ¾ß°¡ °è¼Ó °³Ã´µÇ°í ÀÖ½À´Ï´Ù. ½ÃÀå¿¡´Â ¹ÙÀÌ¿À½Ã¹Ð·¯ Á¦Ç°ÀÇ °³¹ß Ãß¼¼µµ ³ªÅ¸³ª°í ÀÖÀ¸¸ç, ÀÌ´Â °æÀï ½ÉÈ­¿Í Ä¡·á Á¢±Ù¼º Çâ»ó¿¡ ±â¿©ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ¼ÒºñÀÚÀÇ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ¹Ì¿ë Ä¡·á¿¡ ´ëÇÑ ³«ÀÎÀÌ ÁÙ¾îµé°í ÀÖ´Â °Íµµ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ °áÇÕµÇ¾î ±â¼ú Çõ½Å°ú º¸Åø¸®´®Åå½Å ÀÀ¿ë¿¡ ´ëÇÑ ¼ÒºñÀÚ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ½ÃÀåÀÇ °­·ÂÇÑ ¼ºÀåÀ» º¸ÀåÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç° À¯Çü(A À¯Çü, B À¯Çü), ÃÖÁ¾ ¿ëµµ(Ä¡·á, ¹Ì¿ë), ÃÖÁ¾ »ç¿ë ¸ñÀû(Àü¹®¡¤ÇǺΰú Ŭ¸®´Ð, º´¿ø¡¤Áø·á¼Ò, ±âŸ ÃÖÁ¾ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM ¹× ¾÷°èº° SLM Äõ¸®¸¦ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Botulinum Toxin Market to Reach US$11.0 Billion by 2030

The global market for Botulinum Toxin estimated at US$6.7 Billion in the year 2024, is expected to reach US$11.0 Billion by 2030, growing at a CAGR of 8.8% over the analysis period 2024-2030. Type A, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$11.0 Billion by the end of the analysis period. Growth in the Type B segment is estimated at 7.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.9 Billion While China is Forecast to Grow at 16.0% CAGR

The Botulinum Toxin market in the U.S. is estimated at US$3.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 16.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.6% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.6% CAGR.

Global Botulinum Toxin Market - Key Trends & Drivers Summarized

What Is Botulinum Toxin and How Is It Utilized in Modern Medicine?

Botulinum toxin, commonly known as Botox, is a neurotoxic protein produced by the bacterium Clostridium botulinum. It is one of the most poisonous biological substances known, but when purified and used in tiny, controlled doses, it has a variety of important medical and cosmetic applications. Medically, botulinum toxin is used to treat a range of muscle-spasticity disorders, including blepharospasm (uncontrolled blinking), strabismus (crossed eyes), cervical dystonia (painful neck muscle spasms), and chronic migraines. It works by blocking the release of acetylcholine, a neurotransmitter that triggers muscle contraction, thus allowing muscles to relax. Cosmetically, it is most famously used to reduce the appearance of wrinkles by temporarily paralyzing facial muscles, making it a popular anti-aging treatment.

Technological Advancements Enhancing the Efficacy and Safety of Botulinum Toxin Treatments

The field of botulinum toxin therapy has seen significant technological advancements that have enhanced both the efficacy and safety of its applications. Improved purification processes and formulation technology have led to the development of several different types of botulinum toxin products, each tailored for specific therapeutic and aesthetic uses. Innovations in medical imaging and injection techniques have also improved the precision with which the toxin is administered, increasing effectiveness and reducing side effects. Furthermore, ongoing research into the molecular structure and pharmacokinetics of botulinum toxins promises to expand its use by potentially offering new products that could provide longer-lasting effects, quicker onset of action, and reduced immunogenicity.

Emerging Trends in the Applications of Botulinum Toxin

As the global population ages, the demand for cosmetic treatments involving botulinum toxin is witnessing a significant increase, leading to its growing popularity and acceptance. Beyond aesthetics, there is an emerging trend of using botulinum toxin in therapeutic areas with high unmet medical needs, such as in the treatment of overactive bladder, which has provided a new lease on life for patients suffering from this debilitating condition. Additionally, new potential therapeutic applications are being explored, including treatments for depression and anxiety, based on the toxin’s ability to relax muscles and potentially reduce symptoms associated with these mental health conditions. These evolving uses reflect the dynamic nature of this field and demonstrate the potential for botulinum toxin to impact significantly beyond traditional applications.

What Drives the Growth of the Botulinum Toxin Market?

The growth in the botulinum toxin market is driven by several factors, including increased acceptance and demand for minimally invasive aesthetic treatments among both men and women. The rising aging population globally is another major driver, as more individuals seek out treatments to maintain a youthful appearance. Technological advancements that have made treatments safer and more effective also contribute to expanding the market. Furthermore, the broadening of indications for therapeutic use continues to open new segments for growth, catering to a wider range of medical conditions. The market is also seeing a trend towards the development of biosimilar products, which are expected to increase competition and make treatments more accessible. Additionally, growing consumer awareness and decreasing stigma associated with cosmetic treatments are contributing to the market expansion. These factors combined ensure the market's robust growth, driven by both innovation and increasing consumer demand for botulinum toxin applications.

SCOPE OF STUDY:

The report analyzes the Botulinum Toxin market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Type A, Type B); Application (Therapeutics, Aesthetics); End-Use (Specialty & Dermatology Clinics, Hospitals & Clinics, Other End-Uses)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 28 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â